Starbucks Corp vs BIO-TECHNE Corp — how do they compare? Starbucks Corp trades at $104.45 (market cap $119.45B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Starbucks Corp is far larger — about 10.7× BIO-TECHNE Corp's market cap, and Starbucks Corp pays the higher dividend (2.37%). Which is the better fit depends on your goals.
| SBUX | TECH | |
|---|---|---|
Market Cap | $119.45B | $11.16B |
Volume | 7,493,833 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $108.37 | $72.12 |
52-Week Low | $78.46 | $43.31 |
Enterprise Value | $142.14B | $11.24B |
Dividend Yield | 2.37% | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →